Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 288
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05192681 | Tislelizumab as Cross-line Treatment for Advanced NSCLC | ||
| NCT05044871 | Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian Cancer | ||
| NCT05029141 | New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia | ||
| NCT02944708 | Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma | ||
| NCT05179733 | The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years | ||
| NCT04920214 | Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC | ||
| NCT07154316 | Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer | ||
| NCT04843215 | A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer | ||
| NCT03788226 | A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer | ||
| NCT05035446 | Short-term Outcomes of SILS+1 Versus CLS for Distal Gastric Cancer | ||
| NCT06325982 | Clinical Observation of Drug Retention Enema in Preventing Acute Radiation-induced Rectal Injury | ||
| NCT06699459 | Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC | ||
| NCT06140589 | Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer | ||
| NCT02500940 | Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma | ||
| NCT03045770 | mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA | ||
| NCT03788174 | Apatinib Combined With POF for Second-line Treatment of Gastric Adenocarcinoma | ||
| NCT06095154 | CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma | ||
| NCT02448966 | Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy | ||
| NCT01285219 | A Study Comparing Pegylated Filgrastim and Filgrastim in Support for Chemotherapy | ||
| NCT05461664 | Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA | ||
| NCT06490913 | Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes | ||
| NCT06995118 | The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction | ||
| NCT05049811 | Effects of Mobile Medicine on Cancer Patients | ||
| NCT05205200 | Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02 | ||
| NCT04745741 | Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPC | ||
| NCT05479240 | Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer | ||
| NCT04785768 | IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration | ||
| NCT04074538 | the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium | ||
| NCT01218594 | Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer | ||
| NCT02971345 | Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus | ||
| NCT07117851 | A Study of Disitamab Vedotin + Bicalutamide in HER2/AR-Positive Scrotal Paget's Disease | ||
| NCT04174339 | PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer | ||
| NCT07240753 | A Chinese Cohort of Cervical Large Cell Neuroendocrine Carcinoma | ||
| NCT05713994 | Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma | ||
| NCT03351062 | Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer | ||
| NCT06136910 | Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer | ||
| NCT04436965 | Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition | ||
| NCT07256236 | SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer | ||
| NCT05624099 | Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. | ||
| NCT03030937 | Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA | ||
| NCT04121039 | Study of the Apatinib Combine With POF Versus POF in Gastric Cancer | ||
| NCT06612814 | PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer | ||
| NCT05753826 | Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer. | ||
| NCT03308552 | Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02 | ||
| NCT06793917 | Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma | ||
| NCT05198154 | ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC | ||
| NCT02845908 | POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC | ||
| NCT06035250 | AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy | ||
| NCT05335460 | To Determine the Efficacy and Safety of Envafolimab Combined With XELOX for Locally Advanced Colon Cancer | ||
| NCT06061445 | Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma |
